Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06597071

Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely

Use of Oculometric Measures in the Differential Diagnosis of Typical and Atypical Parkinsonian Conditions: a Pilot Study

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
NeuraLight · Industry
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Accepted

Summary

This is an observational longitudinal study in 4 cohorts of patients with Parkinsonian syndromes, who are visiting the Movement Disorders outpatient clinics. The aim of the study is to assess the difference of oculometric measures in different neurodegenerative brain conditions and their accuracy over time, and as compared to clinical diagnosis, in order to find a change over time, difference between subgroups and correlations with accepted clinical endpoints in subjects who meet the inclusion criteria and who provide a signed Informed Consent.

Detailed description

As a part of the study, about 40 subjects will undergo a neurological evaluation including motor and cognitive assessments and a NeuraLight session including oculometric measurements and eye-tracking recordings using a novel software-based platform and an eye-tracking system (Tobii, CE-marked class B approved device). Test duration will be approx. 20 minutes. The oculometric evaluation will occur for at least 50% of the cohort 3 times (at baseline, at 6-months and at 12-month follow-up), and all subjects will be recruited over a period of 9 months. All assessments will be performed during a clinic visit unless authorized to be conducted remotely.

Conditions

Interventions

TypeNameDescription
OTHERNeuraLight PDNeuraLight software-based platform for PD patients
OTHERNeuraLight PSPNeuraLight software-based platform for PSP patients
OTHERNeuraLight MSANeuraLight software-based platform for MSA patients
OTHERNeuraLightNeuraLight software-based platform

Timeline

Start date
2024-09-10
Primary completion
2025-10-01
Completion
2025-12-01
First posted
2024-09-19
Last updated
2025-03-11

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06597071. Inclusion in this directory is not an endorsement.